• Chart
  • F&O
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Granules Share Price

    Granules India Share PriceGranules India

    Mid Cap 9.6k Result
    ₹387.15
    9.2 (2.43%)
    As on 29 November, 2023 | 21:52 BSE: 532482 NSE: GRANULESISIN: INE101D01020

    Granules India Performance

    Day Range

    • Low 379.80
    • High 388.00
    ₹ 387.15

    52 Week Range

    • Low 267.75
    • High 389.95
    ₹ 387.15
    • Open Price380.05
    • Previous Close377.95
    • Volume2926150

    Start SIP in Granules India

    Start SIP

    Granules India Share Price

    • Over 1 Month 18.65%
    • Over 3 Month 28.34%
    • Over 6 Month 37.6%
    • Over 1 Year 11.46%

    Granules India Key Statistics

    P/E Ratio 23.8
    PEG Ratio -1.3
    Market Cap Cr 9,383
    Price to Book Ratio 3.3
    EPS 20.6
    Dividend 0.4
    Relative Strength Index 66.88
    Money Flow Index 72
    MACD Signal 7.98
    Average True Range 10.32

    Granules India F&O

    Granules India Futures
    Granules India Option Chain

    Granules India Investment Rating

    • Master Rating:

    • Granules India has an operating revenue of Rs. 4,516.63 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 15% is great, ROE of 18% is exceptional. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 22% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 3% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 50 which is a POOR score indicating inconsistency in earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 76 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Granules India Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 1,0098211,0141,032964921913
    Operating Expenses Qtr Cr 801664797794778725707
    Operating Profit Qtr Cr 208157217239186197206
    Depreciation Qtr Cr 36353838353532
    Interest Qtr Cr 18151412844
    Tax Qtr Cr 40274348373745
    Net Profit Qtr Cr 11680125140109125129
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 3,9413,256
    Operating Expenses Annual Cr 3,0932,594
    Operating Profit Annual in Cr 838645
    Depreciation Cr 146126
    Interest Annual Cr 3916
    Tax Annual Cr 165133
    Net Profit Annual Cr 499387
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 664280
    Cash from Investing Activity Annual Cr -96-318
    Cash from Financing Annual Activity Cr -519151
    Net Cash Flow Annual Cr 48113
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 2,6992,531
    Fixed Assets Annual Cr 1,3931,381
    Total Non Current Assets Annual Cr 2,1852,042
    Total Current Assets Annual Cr 2,3182,331
    Total Assets Annual Cr 4,5034,373
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 112102
    ROE Annual % 1815
    ROCE Annual % 2419
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2220
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 1,1899861,1961,1461,1511,0201,030
    Operating Expenses Qtr Cr 977849967915908808837
    Operating Profit Qtr Cr 213137228231243212193
    Depreciation Qtr Cr 53494948444340
    Interest Qtr Cr 262219171376
    Tax Qtr Cr 34184443453839
    Net Profit Qtr Cr 10248120124145128111
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 4,5263,783
    Operating Expenses Annual Cr 3,5983,043
    Operating Profit Annual in Cr 914722
    Depreciation Cr 184159
    Interest Annual Cr 5623
    Tax Annual Cr 171145
    Net Profit Annual Cr 517413
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 739332
    Cash from Investing Activity Annual Cr -191-380
    Cash from Financing Annual Activity Cr -440190
    Net Cash Flow Annual Cr 107142
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 2,8352,587
    Fixed Assets Annual Cr 2,1501,897
    Total Non Current Assets Annual Cr 2,3302,008
    Total Current Assets Annual Cr 2,5742,505
    Total Assets Annual Cr 4,9054,513
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 117104
    ROE Annual % 1816
    ROCE Annual % 2420
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2120
    Invest in Granules India

    Granules India Technicals

    EMA & SMA

    Current Price
    ₹387.15
    9.2 (2.43%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹366.15
    • 50 Day
    • ₹351.22
    • 100 Day
    • ₹335.98
    • 200 Day
    • ₹323.28
    • 20 Day
    • ₹364.74
    • 50 Day
    • ₹351.93
    • 100 Day
    • ₹330.27
    • 200 Day
    • ₹309.77

    Granules India Resistance and Support

    PIVOT
    ₹384.99
    Resistance
    First Resistance 390.17
    Second Resistance 393.18
    Third Resistance 398.37
    RSI 66.88
    MFI 72.00
    MACD Single Line 7.98
    MACD 9.53
    Support
    First Resistance 381.97
    Second Resistance 376.78
    Third Resistance 373.77

    Granules India Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 3,036,979 113,097,098 37.24
    Week 3,922,432 133,009,661 33.91
    1 Month 1,908,214 71,119,118 37.27
    6 Month 1,901,548 71,327,064 37.51

    Granules India Result Highlights

    Granules India Synopsis

    NSE-Medical-Diversified

    Granules India L is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3931.20 Cr. and Equity Capital is Rs. 24.20 Cr. for the Year ended 31/03/2023. Granules India Ltd. is a Public Limited Listed company incorporated on 18/03/1991 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1991PLC012471 and registration number is 012471.
    Market Cap 9,383
    Sales 3,877
    Shares in Float 14.06
    No of funds 179
    Yield 0.4
    Book Value 3.47
    U/D Vol ratio 1.9
    LTDebt / Equity 6
    Alpha 0.01
    Beta 1.03

    Granules India

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 41.96%42.02%42.02%42.02%
    Mutual Funds 3.94%4.87%3.76%3.91%
    Insurance Companies 2.92%1.81%1.27%0.84%
    Foreign Portfolio Investors 21.48%21.35%23.9%23.66%
    Financial Institutions/ Banks
    Individual Investors 21.12%21.91%21.14%20.74%
    Others 8.58%8.04%7.91%8.83%

    Granules India Management

    Name Designation
    Mr. Krishna Prasad Chigurupati Chairman & Managing Director
    Dr. K V S Ram Rao Joint Managing Director & CEO
    Mr. Harsha Chigurupati Executive Director
    Mrs. Uma Devi Chigurupati Executive Director
    Mr. K B Sankar Rao Non Exe.Non Ind.Director
    Dr. Saumen Chakraborty Ind. Non-Executive Director
    Mrs. Sucharita Rao Palepu Ind. Non-Executive Director
    Mr. Arun Rao Akinepally Ind. Non-Executive Director
    Mr. Arun Sawhney Ind. Non-Executive Director
    Mr. Kapil Kumar Mehan Ind. Non-Executive Director

    Granules India Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Granules India Corporate Action

    Date Purpose Remarks
    2023-11-09 Quarterly Results
    2023-08-09 Quarterly Results
    2023-05-16 Audited Results & Final Dividend
    2023-01-24 Quarterly Results
    2022-10-20 Quarterly Results
    Date Purpose Remarks
    2023-08-03 FINAL Rs.1.50 per share(150%)Final Dividend
    2022-02-18 INTERIM Re.0.25 per share (25%) Third Interim Dividend
    2021-11-25 INTERIM Re.0.25 per share (25%) Second Interim Dividend
    2021-08-06 INTERIM Rs.0.25 per share(25%)First Interim Dividend
    2021-02-09 INTERIM Rs.0.25 per share (25%) Third Interim Dividend

    Granules India MF Shareholding

    Name Amount(cr)
    Kotak Equity Arbitrage Fund Growth 28,958
    SBI Arbitrage Opportunities Fund Regular Growth 22,370
    ICICI Prudential Equity Arbitrage Fund Regular Growth 15,356
    Nippon India Arbitrage Fund Growth 11,326
    Quant Small Cap Fund Growth 9,521

    Granules India FAQs

    What is Share Price of Granules India ?

    Granules India share price is ₹387 As on 29 November, 2023 | 21:38

    What is the Market Cap of Granules India ?

    The Market Cap of Granules India is ₹9383.3 Cr As on 29 November, 2023 | 21:38

    What is the P/E ratio of Granules India ?

    The P/E ratio of Granules India is 23.8 As on 29 November, 2023 | 21:38

    What is the PB ratio of Granules India ?

    The PB ratio of Granules India is 3.3 As on 29 November, 2023 | 21:38

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.